Jeffrey M. Matherne Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 212 S Kalmia Ave, Highland Springs, VA 23075 Phone: 804-404-3660 |
Disheka Miller Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1901 Repp St, Highland Springs, VA 23075 Phone: 804-901-2315 |
Lichele Jw Billups, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5 N Battery St, Highland Springs, VA 23075 Phone: 804-833-0467 |
News Archive
CytoDyn Inc. ("CytoDyn") (OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, today announced that CytoDyn Chief Medical Officer David Feigal, M.D., has submitted a revised protocol to the U.S. Food and Drug Administration relating to an upcoming Phase IIb clinical trial of PRO 140, CytoDyn's leading product under development as a treatment for Human Immunodeficiency Virus (HIV) infection.
Alzheimer Disease (AD) is characterized by hallmark lesions called amyloid plaques in the brain.
create a set of systems to track people, projects and money. But scientists' formal training doesn't always include business classes. To bridge this gap, Michelle Ozbun, PhD, at the University of New Mexico Cancer Center, is improving a program that helps new scientists learn nuances of conducting science.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today announced the presentation of clinical data from a Phase Ib/II trial conducted by Roche and Genentech to investigate the safety and preliminary efficacy of trastuzumab-DM1 (T-DM1) used in combination with Roche's investigational antibody, pertuzumab.
› Verified 4 days ago